Methamphetamine Abuse in Wisconsin Expands 250 Percent
Wisconsin DOJ, FBI, DEA, and Marshfield Clinic Brief Legislators
MADISON, Wis. – Today, Attorney General Brad Schimel, the Drug Enforcement Administration (DEA), Federal Bureau of Investigation (FBI), Marshfield Clinic, and the Wisconsin Department of Justice (DOJ) Division of Criminal Investigation (DCI), testified at a legislative informational hearing on the growing challenge of methamphetamine abuse in Wisconsin.
“Meth is notorious for not only destroying the user, but the entire family and community around each user,” said Attorney General Schimel. “Wisconsin’s top law enforcement agency has been working with federal law enforcement to assess the threat of meth and every level of government has made a commitment to stop this horrible drug from continuing to destroy our communities. Today’s hearing gave legislators the information they will need to protect their communities and help law enforcement battle back meth.”
“With the increase we’ve seen in meth abuse in our state, it’s essential that lawmakers start getting involved, looking to our law enforcement agencies for advisement,” said Rep. John Spiros, Chair of the Assembly Committee on Criminal Justice and Public Safety. “We’re lucky in Wisconsin to have a Department of Justice that has been dedicated to addressing this problem, and the legislature should be prepared to assist in any way we can. Meth has become a problem in my own area of the state, and I’m looking forward to helping in the next steps to cut down on meth abuse and make our communities safer.”
In January 2017, the FBI released a report detailing the threat of methamphetamine abuse in Wisconsin. The report estimates that from 2011 to 2015, methamphetamine use in Wisconsin likely expanded between 250 and 300 percent. Western Wisconsin and rural areas of the state are seeing the most concentrated use of methamphetamine. The report was a collaborative effort between the FBI, Wisconsin Statewide Intelligence Center, and DOJ. Data was contributed by 96 organizations, including law enforcement, district attorneys, social services, and private organizations.
Mentioned in This Press Release
Recent Press Releases by Brad Schimel
The $920,000 is made available through funding from the U.S. Department of Justice’s Bureau of Justice Assistance.
The coalition argues that the executive order effectively reins in a bureaucracy that has implemented a far greater regulatory burden than Congress ever envisioned.
Amphastar Pharmaceuticals has agreed to continue providing a $6 rebate for each Amphastar naloxone syringe purchased by public entities in Wisconsin from now until February 1, 2018.